Aptinyx Inc. (NASDAQ:APTX) Expected to Post Q1 2024 Earnings of ($0.06) Per Share
Aptinyx Inc. (NASDAQ:APTX) Expected to Post Q1 2024 Earnings of ($0.06) Per Share
Aptinyx Inc. (NASDAQ:APTX – Get Rating) – William Blair issued their Q1 2024 EPS estimates for Aptinyx in a research note issued on Friday, March 31st. William Blair analyst M. Minter forecasts that the company will post earnings per share of ($0.06) for the quarter. The consensus estimate for Aptinyx's current full-year earnings is ($0.56) per share. William Blair also issued estimates for Aptinyx's Q2 2024 earnings at ($0.05) EPS, Q3 2024 earnings at ($0.05) EPS and Q4 2024 earnings at ($0.04) EPS.
Aptinyx 公司（NASDAQ：APTX-獲得評級）— 威廉·布萊爾在 3 月 31 日（星期五）發布的研究報告中發布了 2024 年第一季度每股盈餘的 Aptinyx 估計。威廉·布萊爾分析師 M· 明特預測，該公司將發布本季度每股收益（0.06 美元）。Aptinyx 目前全年盈利的一致估計為每股（0.56 美元）。威廉·布萊爾還發布了 Aptinyx 2024 年第二季盈利（0.05 美元）每股盈利、2024 年第三季盈利為每股盈利（0.05 美元）和 2024 年第四季盈利（0.04 美元）的估計值。
A number of other research firms have also weighed in on APTX. SVB Leerink reissued a "market perform" rating and issued a $0.50 target price on shares of Aptinyx in a report on Wednesday, March 1st. HC Wainwright lowered shares of Aptinyx from a "buy" rating to a "neutral" rating in a report on Tuesday, March 7th. Finally, SVB Securities downgraded Aptinyx from an "outperform" rating to a "market perform" rating in a research report on Wednesday, March 1st. Eight research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $2.58.
許多其他研究公司也稱重 APTX。SVB Leerink 在 3 月 1 日（星期三）的一份報告中重新發布了「市場表現」評級，並發布了 Aptinyx 股票的目標價 0.50 美元。在 3 月 7 日（星期二）的報告中，HC 溫萊特將 Aptinyx 的股票從「買入」評級降至「中性」評級。最後，在 3 月 1 日（星期三）的研究報告中，SVB 證券將 Aptinyx 從「表現大市」評級下調為「市場表現」評級。八位研究分析師對該股票進行了保持評級，兩名研究分析師對該公司發出了買入評級。根據 MarketBeat 的數據，該股目前的共識評級為「持有」，平均目標價為 2.58 美元。
Aptinyx Trading Down 6.5 %
股票交易下跌 6.5%
APTX stock opened at $0.12 on Monday. The firm has a fifty day moving average price of $0.35 and a 200 day moving average price of $0.34. Aptinyx has a fifty-two week low of $0.12 and a fifty-two week high of $2.87. The company has a debt-to-equity ratio of 0.51, a quick ratio of 27.45 and a current ratio of 27.45. The firm has a market cap of $8.45 million, a PE ratio of -0.13 and a beta of 1.39.
APTX 股票在星期一開盤價為 0.12 美元。該公司的五十天移動平均價為 0.35 美元，200 日移動平均價為 0.34 美元。Aptinyx 擁有五十二周低點 0.12 美元，五十二周高點為 2.87 美元。該公司的債務與權益比率為 0.51，快速比率為 27.45，流動比率為 27.45。該公司的市值為 845 萬美元，私募股權比率為 -0.13，測試值為 1.39。
Institutional Trading of Aptinyx
機構交易
A number of institutional investors have recently bought and sold shares of APTX. Jane Street Group LLC lifted its position in shares of Aptinyx by 213.3% during the third quarter. Jane Street Group LLC now owns 105,771 shares of the company's stock worth $39,000 after purchasing an additional 72,006 shares during the last quarter. HBK Sorce Advisory LLC lifted its position in shares of Aptinyx by 100.0% during the fourth quarter. HBK Sorce Advisory LLC now owns 52,000 shares of the company's stock worth $53,000 after purchasing an additional 26,000 shares during the last quarter. Cetera Advisor Networks LLC bought a new stake in shares of Aptinyx during the first quarter worth $92,000. Renaissance Technologies LLC lifted its position in shares of Aptinyx by 14.3% during the fourth quarter. Renaissance Technologies LLC now owns 618,226 shares of the company's stock worth $176,000 after purchasing an additional 77,200 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in shares of Aptinyx by 13.5% during the first quarter. Dimensional Fund Advisors LP now owns 140,711 shares of the company's stock worth $320,000 after purchasing an additional 16,774 shares during the last quarter. 45.93% of the stock is currently owned by institutional investors.
一些機構投資者最近買賣 APTX 的股票。簡街集團有限責任公司在第三季度將其在 Aptinyx 股份的地位提升了 213.3％。簡街集團有限責任公司在上一季度額外購買了 72,006 股股票後，現在擁有該公司股票的 105,771 股價值 39,000 美元。HBK 索爾斯諮詢有限責任公司在第四季度將其在 Aptinyx 股份的地位提升了 100.0％。HBK 索爾斯諮詢有限責任公司現在擁有該公司股票 52,000 股，價值 $53,000 在上一個季度額外購買 26,000 股之後。西泰拉顧問網絡有限責任公司在第一季度價值 92,000 美元期間買了 Aptinyx 股份的新股份。文藝復興技術有限責任公司在第四季度上調了其在 Aptinyx 股份的地位 14.3％。文藝復興科技有限責任公司現在擁有該公司股票的 618,226 股價值 176,000 美元，在上一季度額外購買 77,200 股之後。最後，維基金顧問有限公司在第一季度將其在 Aptinyx 股份的地位上調了 13.5％。維基金顧問 LP 在上一季度額外購買 16,774 股股票後，現在擁有該公司股票的 140,711 股價值 320,000 美元。45.93% 的股票目前由機構投資者擁有。
Aptinyx Company Profile
公司簡介
(Get Rating)
(取得評分)
Aptinyx Inc is a clinical stage biopharmaceutical company, which engages in discovery, development, and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program. The company was founded by Norbert G.
Aptinyx Inc 是一家臨床階段生物製藥公司，致力於大腦和神經系統疾病的轉型療法的發現，開發和商業化。它的產品包括 NYX-2925，NYX-783，NYX-458 和 AGN-241751 程序。該公司由諾伯特 G.
Featured Stories
特色故事
- Get a free copy of the StockNews.com research report on Aptinyx (APTX)
- MarketBeat Week in Review – 3/27 – 3/31
- What is a Gold IRA, and is it a Viable Investment?
- Is Braze Inc Ready To Rocket Higher?
- Mullen Automotive Makes Deliveries; Short-Squeeze Possible
- Can Frontline Maintain This Momentum?
- 免費獲取有關 Aptinyx 研究報告的副本
- 市場節拍週的回顧 — 3 月 27 日 — 3/31
- 什麼是黃金 IRA 退休賬戶，它是一項可行的投資嗎？
- 是 Braze 公司準備火箭更高嗎？
- 穆倫汽車製造交貨；短擠壓成為可能
- 前線可以保持這種勢頭嗎？
Receive News & Ratings for Aptinyx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptinyx and related companies with MarketBeat.com's FREE daily email newsletter.
接收阿普廷尼日報的最新消息和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件時事通訊接收 Aptinyx 及相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。